Aura Biosciences (AURA) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free AURA Stock Alerts $7.10 -0.17 (-2.34%) (As of 04:26 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aura Biosciences Short Interest DataCurrent Short Interest2,760,000 sharesPrevious Short Interest2,580,000 sharesChange Vs. Previous Month+6.98%Dollar Volume Sold Short$20.42 millionShort Interest Ratio15.6 Days to CoverLast Record DateApril 30, 2024Outstanding Shares49,540,000 sharesFloat Size39,730,000 sharesShort Percent of Float6.95%Today's Trading Volume81,951 sharesAverage Trading Volume161,176 sharesToday's Volume Vs. Average51% Short Selling Aura Biosciences ? Sign up to receive the latest short interest report for Aura Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAURA Short Interest Over TimeAURA Days to Cover Over TimeAURA Percentage of Float Shorted Over Time Ad InvestorPlaceThis Could be Your “Big Money” AI MomentBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Aura Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,760,000 shares $20.42 million +7.0%7.0%15.6 $7.40 4/15/20242,580,000 shares $19.48 million +5.3%6.5%14.2 $7.55 3/31/20242,450,000 shares $19.23 million +9.4%6.2%13.6 $7.85 3/15/20242,240,000 shares $16.13 million +4.7%7.3%12.3 $7.20 2/29/20242,140,000 shares $19.41 million -15.4%6.9%14.3 $9.07 2/15/20242,530,000 shares $22.01 million +2.0%8.2%16.8 $8.70 Get the Latest News and Ratings for AURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aura Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,480,000 shares $19.10 million -5.7%8.2%10.9 $7.70 1/15/20242,630,000 shares $22.01 million -1.9%8.6%11.7 $8.37 12/31/20232,680,000 shares $23.74 million +10.3%8.8%12.4 $8.86 12/15/20232,430,000 shares $21.87 million -4.3%7.9%11.7 $9.00 11/30/20232,540,000 shares $20.37 million -3.1%8.3%14.4 $8.02 11/15/20232,620,000 shares $21.20 million +2.0%8.6%16.7 $8.09 10/31/20232,570,000 shares $20.97 million -4.1%8.7%19.3 $8.16 10/15/20232,680,000 shares $22.70 million No Change9.1%47.9 $8.47 9/30/20232,680,000 shares $24.04 million +0.8%9.1%51.4 $8.97 9/15/20232,660,000 shares $25.03 million -0.8%9.0%51.7 $9.41 8/31/20232,680,000 shares $27.82 million -2.9%9.1%37.2 $10.38 8/15/20232,760,000 shares $28.15 million -1.4%9.3%37.7 $10.20 7/31/20232,800,000 shares $33.32 million +0.4%9.7%37.6 $11.90 7/15/20232,790,000 shares $34.07 million -0.4%9.6%34.2 $12.21 6/30/20232,800,000 shares $34.58 million +2.2%9.7%32.8 $12.35 6/15/20232,740,000 shares $34.55 million +24.6%9.5%29.5 $12.61 5/31/20232,200,000 shares $24.90 million +35.0%7.6%21.2 $11.32 5/15/20231,630,000 shares $17.49 million -3.0%6.2%15.1 $10.73 4/30/20231,680,000 shares $15.19 million +2.4%6.4%15.2 $9.04 4/15/20231,640,000 shares $14.27 million +5.1%6.2%14.3 $8.70 3/31/20231,560,000 shares $14.48 million +24.8%6.0%13.1 $9.28 3/15/20231,250,000 shares $12.73 million +30.2%4.8%10.8 $10.18 2/28/2023960,000 shares $9.59 million +22.3%4.8%11.7 $9.99 2/15/2023785,000 shares $8.75 million +27.0%3.9%7.9 $11.15 1/31/2023618,100 shares $6.43 million +41.3%3.1%5.7 $10.41 1/15/2023437,500 shares $4.99 million -36.4%2.2%4.6 $11.40 12/30/2022688,300 shares $7.23 million +38.7%3.9%7.2 $10.50 12/15/2022496,400 shares $5.93 million -53.2%2.8%5.3 $11.95 11/30/20221,060,000 shares $15.14 million +1.9%6.0%10.1 $14.28 11/15/20221,040,000 shares $14.14 million -14.1%5.8%12.5 $13.60 10/31/20221,210,000 shares $14.99 million -4.7%6.8%16.6 $12.39 10/15/20221,270,000 shares $17.22 million -3.8%7.1%17.6 $13.56 9/30/20221,320,000 shares $23.92 million +4.8%7.4%19.5 $18.12 9/15/20221,260,000 shares $18.11 million +3.3%7.1%13.5 $14.37This Could be Your “Big Money” AI Moment (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. 8/31/20221,220,000 shares $16.30 million -7.6%6.8%11.4 $13.36 8/15/20221,320,000 shares $24.88 million -1.5%7.4%12 $18.85 7/31/20221,340,000 shares $19.11 million -0.7%7.5%12.6 $14.26 7/15/20221,350,000 shares $19.39 million +10.7%7.6%12.5 $14.36 6/30/20221,220,000 shares $17.29 million +27.7%6.9%11.2 $14.17 6/15/2022955,600 shares $13.11 million +17.8%5.4%9.8 $13.72 5/31/2022810,900 shares $14.17 million +15.4%4.5%16.4 $17.47 5/15/2022703,000 shares $11.63 million +9.4%3.9%16.9 $16.54 4/30/2022642,500 shares $10.90 million +23.6%3.6%17 $16.96 4/15/2022519,900 shares $9.28 million +56.1%2.9%16.5 $17.85 3/31/2022333,000 shares $7.33 million +73.3%1.8%11.5 $22.00 3/15/2022192,200 shares $4.14 million +53.9%1.1%5 $21.53 2/28/2022124,900 shares $2.24 million -0.9%0.7%2.2 $17.90 2/15/2022126,000 shares $2.64 million -2.0%0.7%1.9 $20.99 1/31/2022128,500 shares $2.35 million +26.9%0.7%1.5 $18.25 1/15/2022101,300 shares $1.66 million +0.8%0.6%0.7 $16.40 12/31/2021100,500 shares $1.71 million No Change0.6%0.6 $16.98 AURA Short Interest - Frequently Asked Questions What is Aura Biosciences' current short interest? Short interest is the volume of Aura Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,760,000 shares of AURA short. 6.95% of Aura Biosciences' shares are currently sold short. Learn More on Aura Biosciences' current short interest. What is a good short interest ratio for Aura Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AURA shares currently have a short interest ratio of 16.0. Learn More on Aura Biosciences's short interest ratio. Which institutional investors are shorting Aura Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aura Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aura Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.95% of Aura Biosciences' floating shares are currently sold short. Is Aura Biosciences' short interest increasing or decreasing? Aura Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,760,000 shares, an increase of 7.0% from the previous total of 2,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aura Biosciences' float size? Aura Biosciences currently has issued a total of 49,540,000 shares. Some of Aura Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aura Biosciences currently has a public float of 39,730,000 shares. How does Aura Biosciences' short interest compare to its competitors? 6.95% of Aura Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Aura Biosciences: Tourmaline Bio, Inc. (20.12%), Solid Biosciences Inc. (3.01%), Anavex Life Sciences Corp. (25.15%), Tenaya Therapeutics, Inc. (5.80%), Replimune Group, Inc. (19.05%), C4 Therapeutics, Inc. (14.74%), MeiraGTx Holdings plc (1.76%), Caribou Biosciences, Inc. (13.35%), Black Diamond Therapeutics, Inc. (3.56%), TScan Therapeutics, Inc. (1.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aura Biosciences stock? Short selling AURA is an investing strategy that aims to generate trading profit from Aura Biosciences as its price is falling. AURA shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aura Biosciences? A short squeeze for Aura Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AURA, which in turn drives the price of the stock up even further. How often is Aura Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AURA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TRML Short Interest SLDB Short Interest AVXL Short Interest TNYA Short Interest REPL Short Interest CCCC Short Interest MGTX Short Interest CRBU Short Interest BDTX Short Interest TCRX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AURA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWarren Buffett's "mystery stock"Stansberry ResearchDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company